Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Blood Advances
|
May 31, 2018
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
Andrew C Harris, Jaap J Boelens, Kwang Woo Ahn, et al.
British Journal of Haematology
|
January 11, 2024
Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report
Binni Kunvarjee, Gloria Paz Contreras Yametti, Amanda G Blouin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621
Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Transplantation and Cellular Therapy
|
August 31, 2022
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study
Paul A Carpenter, Hyoung Jin Kang, Keon Hee Yoo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality
Margaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2015
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C Harris, Rachel Young, Steven Devine, et al.
Bone Marrow Transplantation
|
February 27, 2025
Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Gabrielle Meyers, Mehdi Hamadani, Michael Martens, et al.
Bone Marrow Transplantation
|
September 25, 2023
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Gabrielle Meyers, Mehdi Hamadani, Michael Martens, et al.
Blood Advances
|
November 9, 2021
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation
Muna Qayed, Benjamin Watkins, Scott Gillespie, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Blood Advances
|
May 31, 2018
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
Andrew C Harris, Jaap J Boelens, Kwang Woo Ahn, et al.
British Journal of Haematology
|
January 11, 2024
Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report
Binni Kunvarjee, Gloria Paz Contreras Yametti, Amanda G Blouin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2022
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621
Maureen M O'Brien, Lingyun Ji, Nirali N Shah, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Transplantation and Cellular Therapy
|
August 31, 2022
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study
Paul A Carpenter, Hyoung Jin Kang, Keon Hee Yoo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality
Margaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2015
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C Harris, Rachel Young, Steven Devine, et al.
Bone Marrow Transplantation
|
February 27, 2025
Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Gabrielle Meyers, Mehdi Hamadani, Michael Martens, et al.
Bone Marrow Transplantation
|
September 25, 2023
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Gabrielle Meyers, Mehdi Hamadani, Michael Martens, et al.
Blood Advances
|
November 9, 2021
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation
Muna Qayed, Benjamin Watkins, Scott Gillespie, et al.
Page
of 10